INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT, CUSTOMER PASSED AWAY AT HOME ON (B)(6) 2022. THE CUSTOMER WAS NOT ADMITTED TO A HOSPITAL PRIOR TO THE REPORTED INCIDENT. THE CUSTOMER PASSED AWAY IN SLEEP. THE CAUSE FOR DEATH AND CUSTOMERøS BLOOD GLUCOSE VALUE WAS UNKNOWN. THE CUSTOMER WAS WEARING THE INSULIN PUMP AT THE TIME OF DEATH. THE CUSTOMER WAS NOT USING THE SENSOR. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.
CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY "DEFECTS" OR HAS "MALFUNCTIONED". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT.
A PERITONEAL DIALYSIS (PD) PATIENT EXPERIENCED FIVE EPISODES OF PERITONITIS. THE "FIFTH" PERITONITIS WAS CONFIRMED TO BE ENCAPSULATED SCLEROSING PERITONITIS. ON THE SAME DAY AS THE EVENT ONSET, THE PATIENT WAS HOSPITALIZED FOR THE EVENT. PD CATHETER WAS REMOVED WITHIN A DAY OR 2 OF HOSPITAL ADMISSION AND WITHDREW FROM TREATMENT. THE CAUSE, TREATMENT AND PATIENT OUTCOME WERE NOT REPORTED. AFTER HOSPITAL DISCHARGE 16 DAYS AFTER THE ONSET OF THE "FIFTH" PERITONITIS, THE PATIENT PASSED AWAY. THE CAUSE OF DEATH WAS REPORTED AS DUE TO THE PATIENT WITHDREW FROM TREATMENT AS THE PATIENT DID NOT WANT TO TRANSITION ONTO LIFE OF HEMODIALYSIS. AUTOPSY WAS NOT PERFORMED. IT WAS NOT REPORTED IF THE PATIENT HAS RECOVERED FROM THE PERITONITIS EVENT PRIOR TO OR AT THE TIME OF DEATH. NO ADDITIONAL INFORMATION IS AVAILABLE.
THE DEVICE WAS NOT RETURNED AND THE LOT NUMBER IS UNKNOWN; THEREFORE, A DEVICE ANALYSIS COULD NOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
IT WAS REPORTED THAT POST IMPLANT THE†LEADLESS IMPLANTABLE PULSE GENERATOR (IPG) EXHIBITED HIGH THRESHOLDS AND INTERMITTENT CAPTURE WITH THE PATIENTS QRS WIDENING. THE DEVICE WAS REPOSITIONED AND REPROGRAMMED HOWEVER, THE PATIENT DEVELOPED METABOLIC ACIDOSIS CAUSING LOSS OF CAPTURE. THE PATIENT THEN CODED AND PASSED AWAY.